Statin Therapy Results in the Real World Practice in the Czech Republic

AstraZeneca3,253 enrolled

Overview

Statins are the first choice treatment of dyslipidemia, a major contributor to cardiovascular diseases. Statins also have enough evidence to demonstrate decrease of morbidity and mortality from cardiovascular diseases. Even though statin therapy is effective treatment of dyslipidaemia not all patients reach the goal levels. The aim of the study is to estimate proportion of patients who achieved the therapeutic goal (LDL-C. total cholesterol, HDL-C and triglycerides levels) after at least one year of a statin therapy.

Study Type

OBSERVATIONAL

Enrollment

3,253

Conditions

Dyslipidaemia

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Documented statin therapy for at least 12 months * Available two LDL-C values: one at the beginning of statin therapy or at the time when patient comes to a specialist; and the other one at least after 12 months of treatment. The latter value should not be older than 6 months. Exclusion Criteria: \-

Locations (95)

Outcomes

Primary Outcomes

LDL-C

Time frame: one year

Secondary Outcomes

Total cholesterol

Time frame: one year

HDL-C

Time frame: one year

triglycerides

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Research Site

Benešov, Czechia

Research Site

Beroun, Czechia

Research Site

Blansko, Czechia

Research Site

Bohumín, Czechia

Research Site

Boskovice, Czechia

Research Site

Brandýs nad Labem, Czechia

Research Site

Brno, Czechia

Research Site

Cheb, Czechia

Research Site

Chomutov, Czechia

Research Site

Chrudim, Czechia

...and 85 more locations